Novartis now expects its core operating profit to grow in the mid to high teens, after second-quarter results outpaced analysts’ expectations, boosted by revenue from its blockbuster treatments.
Trending
- Josh Brolin, Julia Garner In Zach Cregger Horror
- Starfighter’ Enlists Matt Smith in Villain Role
- Loni Anderson Talks ‘WKRP,’ ‘Nurses’ and Burt Reynolds
- From ingredient costs to sagging demand, tariffs further pinch company earnings
- French box office continues summer slump with 17% drop in ticket sales in July | News
- Family pay tribute to Oasis fan Lee Claydon who died at Wembley
- Timothée Chalamet, James Mangold Pitching Heist Movie High Side
- Deir al-Balah resident speaks to France24 about Gaza’s famine and humanitarian conditions
